We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

AI Platform Identifies 99% of Positive Cancer Cases in Pathology Reports

By HospiMedica International staff writers
Posted on 14 Mar 2022

For most people, the shock of a cancer diagnosis quickly gives way to an action plan — disease research, doctor appointments, treatment options, and support outlets. More...

But many patients are not able to take these steps or advocate for themselves. Some simply don't know how to move forward, which results in more complicated and expensive care, reduced life expectancies, and inferior health outcomes. A new artificial intelligence (AI) platform disrupts the manual and repetitive processes in healthcare to identify positive cancer diagnosis and incidental findings in real time, classify those diagnoses by primary site, and route those patients to cancer navigators and other staff to immediately start the cancer care journey.

The results of this new platform from Azra AI (Franklin, TN, USA) include faster time to treatment, increased navigator time with patients, and better patient retention in a health system's oncology program. In addition, Azra AI's platform improves healthcare operations with dramatic operational and financial gains through automation. More specifically, this new technology decreased time from diagnosis-to-treatment by seven days across all cancer types, improved patient retention by 75% and increased revenues over 10% in the first 14 months of use.

Azra AI's technology is making a tremendous impact in the oncology realm and has saved countless hours for hospital staff by combing through CT scan results with exceptional speed and accuracy. Healthcare leaders have also found that the Azra AI platform performs better than manual processes and completes reviews much faster. A recent analysis of one health system's records using the Azra AI platform found that the technology identified 99% of positive cancer cases in pathology reports that had previously been manually reviewed by healthcare staff.

"We are already helping thousands of cancer patients and clinicians everyday with our AI-enhanced intelligent workflows," said Azra AI CEO Chris Cashwell. "With the crisis in nurse staffing and uncertainty of post-COVID cancer patient volumes, our technology can be a lifeline to clinicians and a life saver for patients. From finding incidental lung nodules to reducing time to treatment, providers are having a profound impact using our technology."

Related Links:
Azra AI 


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Patient Monitoring System
AlarmSense
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.